119: SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-small cell lung cancer (NSCLC). A UK randomised phase III trial.

Authors :: Landau, D.B.
Hughes, L.
Ngai, Y.
Hanna, G.G.
Conibear, J.
Farrelly, L.
Counsell, N.
Source :: Lung Cancer (01695002). Jan2017 Supplement 1, Vol. 103, pS54-S54. 1p.
Publication Year :: 2017

Subjects :: *CANCER treatment
*NON-small-cell lung carcinoma
*STEREOTACTIC radiotherapy
*RANDOMIZED controlled trials
*CANCER radiotherapy
*ABLATION techniques

Full Text Access

Tools